Gago, Sara http://orcid.org/0000-0002-7027-4598
Overton, Nicola L. D.
Ben-Ghazzi, Nagwa
Novak-Frazer, Lilyann http://orcid.org/0000-0002-1434-3915
Read, Nick D.
Denning, David W.
Bowyer, Paul
Funding for this research was provided by:
Medical Research Council (MR/M02010X/1)
National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/P002390/1)
Fungal Infection Trust
Article History
Received: 17 October 2017
Accepted: 27 July 2018
First Online: 20 September 2018
Competing interests
: N.B.G., L.N.F., D.W.D. and P.B. declare the following competing interests related to this research. N.B.G. has been paid for talks on behalf of Nawgen SL. L.N.F. has been paid travel expenses and she has written and presented on resistance monitoring using pyrosequencing for Gilead GAIN education programme. D.W.D. and family hold founder shares in F2G Ltd., an antifungal discovery company and in Novocyt, which markets the Myconostica real-time molecular assays. D.W.D. has a patent for fungal infection assays that has been externally licensed; he acts or has recently acted as a consultant to Astellas, Sigma Tau, Basilea, Scynexis, Cidara, Biosergen, Quintilles, and Pulmocide; and in the last 3 years he has been paid for talks on behalf of Astellas, Dynamiker, Gilead, Merck, and Pfizer. P.B. is a founder of Alergenetica SL. and Syngenics Ltd. None of the other authors have a relevant financial conflict of interest. S.G. is a council member of the International Society of Human and Medical Mycology (ISHAM). N.B.G. has been the head of the Libyan Medical Laboratory Association. N.R. has been a President of the British Mycological Society, a Fellow of the Royal Society of Biology and of the Royal Microscopical Society. D.W.D. is a longstanding member of the Infectious Disease Society of America Aspergillosis Guidelines Group, the European Society for Clinical Microbiology and Infectious Diseases Aspergillosis Guidelines Group and the British Society for Medical Mycology Standards of Care Committee. None of the other authors have a relevant non-financial conflict of interest.